Office for Human Research Studies

The Office for Human Research Studies (OHRS) oversees the scientific and Institutional Review Board review processes for all cancer relevant research conducted by the five Harvard clinical institutions under the umbrella of Dana-Farber/Harvard Cancer Center. OHRS is responsible for ensuring the administrative and regulatory management, implementation, and operation of the Protocol Review and Monitoring System; the system for the institutional review board review of research;  the Health Improvement Portability and Accountability Act as it relates to research; and activation of Research Protocols.

OHRS News & Updates

  • September 06, 2018 – Office for Human Research Studies

    The HHS office for Human Research Protections will present a continuing education opportunity on Friday, September 7, 2018. A livestream of the workshop will be available to the public.

  • August 10, 2018 – Office for Human Research Studies

    OHRS has released the following new and revised forms. Please read carefully because as of September 10, 2018, older versions of these templates and forms will no longer be accepted by OHRS.

  • July 25, 2018 – Office for Human Research Studies

    The NCI Central IRB (CIRB) has recently approved updated DF/HCC consent boilerplate language which applies to any DF/HCC studies which rely on the NCI CIRB. This change will affect the process for merging the DF/HCC...

Most Accessed Documents 

  • Link
  • Link
  • Link
  • Link

In order to open .pdf files using Adobe Reader, you must download the document to your desktop, and then open it from there. This is done by right-clicking (or command-clicking) the link and selecting "Save link as." Otherwise, the document may not display correctly (or at all).

Filter this list Learn how this search works
Filter this list

Enter a search term to filter the list below

Pre-Submission (creation)

New Protocol Submissions

Post-Activation Submissions (conduct)

Close-out Submissions (study completion)